HIV+Hep in the News

Appointees’ confusion over HIV programs may lead to funding cuts

President Trump should not undermine the historic progress made in his first administration, says Carl Schmid, executive director of the HIV + Hepatitis Policy Institute. “With new long-acting PrEP drugs on the horizon, now is not the time to totally disrupt the system but a time to redouble our efforts to prevent HIV. President Trump was right, we can end HIV, but we need the right policies and funded programs in place to make that a reality,” Schmid said.

read more

CDC’s HIV prevention division reportedly under threat

“We cannot end HIV without a fully functioning and sufficiently funded HIV prevention program. If the administration has new ideas on how to conduct HIV prevention, including testing, surveillance, education, and PrEP outreach, we are more than willing to discuss them,” stated Carl Schmid, a gay man who is executive director of the HIV+Hepatitis Policy Institute. “With new long-acting PrEP drugs on the horizon, now is not the time to totally disrupt the system but a time to redouble our efforts to prevent HIV.”

read more

HHS may cut HIV prevention efforts at the CDC. Advocates fear changes will spike infections

Carl Schmid, executive director of the HIV+Hepatitis Policy Institute said in a statement that both President Donald Trump and HHS Secretary Robert F. Kennedy Jr. have committed to combating HIV. “President Trump during his first term initiated the Ending the HIV Epidemic initiative, an historic effort to end HIV in the US by 2030,” Schmid said. “HHS Secretary Kennedy has stated on the record as part of his confirmation process that he ‘look[s] forward to continuing the good work that President Trump did in his pursuit to eradicate HIV/AIDS’ and that ‘HHS will support all appropriate prevention programs, including those which include pre-exposure prophylaxis.’

read more

Pin It on Pinterest

HIV+Hepatitis Policy Institute
Share This